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ABSTRACT Tomonitor binding of tropomyosin to yeast actin, wemutated S235 to C and labeled the actin with pyrenemaleimide
at both C235 and the normally reactive C374. Saturating cardiac tropomyosin (cTM) caused about a 20% increase in pyrene
ﬂuorescence of the doubly labeled F-actin but no change in WT actin C374 probe ﬂuorescence. Skeletal muscle tropomyosin
caused only a 7% ﬂuorescence increase, suggesting differential binding modes for the two tropomyosins. The increased cTM-
induced ﬂuorescence was proportional to the extent of tropomyosin binding. Yeast tropomyosin (TPM1) produced less increase in
ﬂuorescence than did cTM, whereas that caused by yeast TPM2 was greater than either TPM1 or cTM. Cardiac troponin largely
reversed the cTM-induced ﬂuorescence increase, and subsequent addition of calcium resulted in a small ﬂuorescence recovery.
An A230Y mutation, which causes a Ca12-dependent hypercontractile response of regulated thin ﬁlaments, did not change
probe235 ﬂuorescence of actin alone or with tropomyosin 6 troponin. However, addition of calcium resulted in twice the
ﬂuorescence recovery observed withWT actin. Our results demonstrate isoform-speciﬁc binding of different tropomyosins to actin
and suggest allosteric regulation of the tropomyosin/actin interaction across the actin interdomain cleft.
INTRODUCTION
The tropomyosins (TMs) are a family of conserved eukary-
otic F-actin binding proteins with molecular masses from
19 to 40 KDa (1,2). TM has a dimeric a-helical coiled-coil
structure and contains four to seven quasirepeat regions,
depending on the TM isoform. Each quasirepeat contacts a
separate actin monomer when the protein binds to the actin
ﬁlament, but the contribution of different pseudorepeats to
the binding of TM to actin is not equivalent (3,4). The
overlapping interaction of termini on neighboring TMs is
important for the binding of TM to the actin ﬁlament (5,6).
Nonmuscle TM is believed to play an important role in
maintaining the integrity of the actin cytoskeleton (7).
Previous studies have demonstrated that TM can restore
polymerizability to a polymerization-defective yeast actin
mutant V266G, L267G (8). Liu et al. found that deletion of
yeast TM1 (TPM1), which comprises;85% of the total TM
in the cell, led to disruption of actin cables and resulted in a
temperature-sensitive phenotype (9,10). Overexpression of a
second minor yeast TM, TPM2, in the mutant cells largely
rescued the phenotype described above (11). Overexpression
of TPM1 in yeast cells also rescued the defect in actin cable
formation caused by mutations in other genes like mdm20,
which catalyzes the N-acetylation of TM (12). The interface
in the actin/TM complex has not yet been characterized, and
it has been proposed that there are no speciﬁc contacts
between the two proteins. Instead there may be merely a
loose interaction between complementary charged surfaces
(13).
In muscle cell contraction, the actin thin ﬁlament is the
transducer of the force exerted by the myosin head. This
process is highly controlled at the level of the thin ﬁlament
by the calcium-regulated TM/troponin complex (14). Tro-
ponin (TN) is a TM-associated protein composed of three
subunits, TNC, I, and T. The efﬁciency of contraction is dic-
tated in large part by the contacts at the actin/myosin inter-
face and may also depend on the conformational changes in
the actin exerted by its interaction with myosin and the two
regulatory proteins (15).
Calcium regulation of myosin activity in muscle cells,
dependent on the intermediacy of the TM/TN complex, can
be described by a three-state model (16). In this model, in the
absence of Ca21 binding to the low afﬁnity site(s) on TNC,
the TM/TN complex sits on the actin thin ﬁlament in a
manner that sterically blocks the ability of the myosin head
to interact with the actin (blocked or B-state). Upon the
binding of Ca21 to the TNC subunit, a conformational
change in the complex occurs, resulting in its translation over
the actin surface to a more inner position on the ﬁlament
(closed or C-state). These states are depicted in Fig. 1. This
movement now allows partial accessibility of the myosin
head to binding sites on the actin. This actin/myosin
interaction now forces the TM/TN complex even further
toward the ﬁlament center, allowing the strong actin/myosin
complex to form, which ultimately results in the generation
of contractile force (open or M state).
Results of recent high resolution electron microscopy
studies using both full length and shortened TMs are
generally consistent with this three-state model (17). Sub-
sequent work revealed that the position of binding of TM to
actin depended both on the nature of the actin isoform and
the nature of the TM. Electron microscopy (EM) studies
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showed that skeletal muscle TM (skTM) binds in the C-state
to muscle actin, bridging the cleft borders of subdomains 2
and 4 of the actin. However, it binds in the B-state on a yeast
actin ﬁlament, running through the middle of subdomains
1 and 2 (18). It has also been demonstrated that with skeletal
muscle actin, cardiac and smooth muscle TMs are in the
B-state instead of the C-state where skTM binds (18). The
position of binding of bovine cardiac TM (cTM) to yeast
actin has not been assessed by EM.
A number of studies have used ﬂuorescently labeled TMs
to assess the behavior of TM on the actin ﬁlament in
solution. Ishii and Lehrer (19) used the excimer formed by
pyrene-labeled TM to study the kinetics of the on-off change
of TM resulting from the displacement of myosin S1 from
the actin ﬁlament. Graceffa (20) used ﬂuorescence energy
transfer between a donor probe on TM and an acceptor probe
on C374 of actin to assess the movement of smooth muscle
TM caused by myosin heads. Chandy et al. (21) used the
polarized phosphorescence of erythrosine-labeled TM to
measure the microsecond rotational dynamics of cardiac
versus skTMs on the actin surface. They concluded that the
cTM was more mobile than its skeletal muscle counterpart.
Finally, Bacchiocchi and Lehrer (22,23) have employed
multisite ﬂuorescence resonance energy transfer to study the
problem. They used a naphthalene derivative attached to TM
as a donor and rhodamine phalloidin attached to actin as an
acceptor. They then applied a sophisticated mathematical
analysis to the data they acquired. With this approach, they
demonstrated ﬁrst that TM can roll over the actin surface.
They also used the system to demonstrate myosin-induced
movement of different smooth muscle TMs on actin. The
ability to easily measure such movement is important to
appreciate the molecular basis of the regulation of muscle
contractility, but the technology involved in these newer
studies is not straightforward. Routine assessment of the
motion of these proteins over actin, from actin’s perspective,
has been difﬁcult in part because of a lack of convenient sites
on actin to attach critically placed ﬂuorescent probes for
detection of changes in binding.
Yeast provides a convenient system for generating
mutated actins in large enough quantities for biochemical
studies (24). Mutations can be introduced which will either
test the importance of speciﬁc residues in actin function or
provide attachment sites for ﬂuorescent probes. Yeast actin,
87% identical with muscle actin (25), is encoded by a single
gene, and it can easily be replaced by a gene carrying the
FIGURE 1 Actin structural models. (A) Depiction of
actin/TM binding states and the actin mutations used in
this study. (Left) Shown are the approximate binding
regions for TM on actin in the blocked (B), closed (C),
and open (M) states. The binding envelopes are based
on work by Lehman and colleagues (17,18). Roman
numerals I–IV denote the four subdomains of actin.
Highlighted are amino acid residues E224 (red), A230
(green), S235 (blue), M305 (orange), and C374 (purple).
An ATP/ADP binding site is located at the bottom of
the central cleft. (Right) Side view (subdomains III and
IV face forward) of the actin monomer. The G-actin
structure was constructed based on the yeast actin
atomic coordinates (PDB, 1YAG (27)). (B) The
distance between the C374 and the E224 in the actin
ﬁlament. The F-actin model is constructed based on the
Holmes model with the hydrophobic 3/4 loop extended
(52). The mutated residues and C374 in each actin
monomer are highlighted with the same color scheme
as described for panel A. The distance between the
sulfur of C374 in Unit 3 of the actin monomer and the
g-carbon of E224 in Unit 2 of the actin monomer is
;21 A˚. Not shown in the ﬁgure are the following
intraresidue differences in which 374 is in Unit 3 and
the remaining residues are in Unit 2: 374–230, 19.6 A˚;
374–235, 28.7 A˚; 374–305, 39 A˚. Residue 230 is
pointing in the opposite direction from 374 and thus
probes attached to these two could not interact. The
235 and 305 residues are on the opposite face of actin
from 374, and attached probes would thus be blocked
by intervening mass from interacting with a pyrene at
374.
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mutated site of choice (26). Its tertiary structure is almost
identical to that of muscle actin (27). Yeast actin is a valid
model for studying regulation of thin ﬁlament activity since
previous studies have shown that its ability to activate
muscle S1 ATPase activity can be controlled in vitro by
TM/TN in much the same way as muscle F-actin (28).
In this study, we investigate the interaction between actin
and TM and the effect TN exerts on this complex. Lorenz’s
model (13) and recent EM studies of the actin/TM interaction
(17) suggested that two amino acids on subdomain 4, res-
idues 235 and 305, might represent convenient attachment
sites for probes to assess the interaction of TM with actin
(Fig. 1 A). To test this hypothesis, we separately mutated
yeast actin Ser235, Glu224, and Met305 to Cys so that we could
label these two sites with pyrene maleimide. One can thus
potentially investigate the effect of the interaction among
actin, TM, and TN on these two sites by monitoring the
change in pyrene ﬂuorescence caused by the interaction of
actin and TM, assuming the probes are in the correct position
to report on such an interaction.
We have used this system to assess whether there are
differences in the interaction of yeast TPM1, yeast TPM2,
cTM, and skTM with actin and to assess the effect of TN on
the actin/TM interaction. Finally, we have studied the effect
of an A230Y mutation on the ﬂuorescence behavior of this
probe. This mutation, in the presence of TM/TN, causes a
hypercontractile response to Ca21. We have assessed
whether or not the A230Y substitution might result in a
change in the environment sampled by the pyrene235 in the
presence of cTM and cardiac TN (cTN).
MATERIALS AND METHODS
Materials
The DNA primers used for site-directed mutagenesis were obtained from
Integrated DNA Technologies (Coralville, IA). N-(1-pyrenyl)maleimide was
purchased from Sigma-Aldrich (St. Louis, MO). The yeast cake used for WT
actin puriﬁcation was purchased locally. Bovine cardiac TM (cTM), which
is;85% a-isoform and 15% b-isoform (29), yeast TPM1, and yeast TPM2
were puriﬁed from cardiac acetone powder and yeast cells, respectively,
according to methods described previously (30,31). Bovine cTN, and
skeletal muscle (skTM), which is an a,b TM mixture, were the generous
gifts of Larry Tobacman and Emil Reisler, respectively.
Mutagenesis and plasmid construction
Plasmid puriﬁcation and manipulation were performed according to
methods described previously (32). Site-directed mutagenesis was per-
formed using kits purchased from Stratagene (La Jolla, CA), according to the
manufacturer’s instructions. The template plasmid is the TRP1-marked
centromeric plasmid pRS314-WN (33) in which the yeast ACT1 promoter
and coding sequence had been cloned between the BamH I and EcoR I sites
in the polylinker site of pRS314 (34). S235C, M305C, E224C, and A230Y/
mutations were successfully constructed, and all plasmids were sequenced to
conﬁrm the correctness of the DNA sequences. Plasmids containing the
mutant actin sequences were introduced into a ura3, trp1, leu2 haploid yeast
cell in which the chromosomal actin gene had been disrupted by a LEU2
gene. In this cell, the WT actin was expressed from another centromeric
plasmid marked with the URA3 gene. pRS314 transformed cells were
selected for by growth in Trp-deﬁcient medium. Plasmid shufﬂing produced
viable haploid cells expressing only the mutant actins. The plasmids were
reisolated from the transformed yeast and sequenced to conﬁrm the presence
of the desired actin mutation.
Actin puriﬁcation and labeling of actin with
pyrene maleimide
Actins were puriﬁed from the mutant cells by DNase I afﬁnity chromatog-
raphy and diethylaminoethyl cellulose chromatography as described previ-
ously (35,36), and puriﬁed actins were stored in G buffer (10 mM Tris-HCl,
pH 7.5, containing 0.2 mM ATP, 0.2 mM CaCl2, and 0.1 mM DTT) at 4C
and used for experiments within 3 days. Pyrene labeling of actins was
performed as described previously (37) with modiﬁcations as follows.
Before pyrene labeling, actins were dialyzed against G buffer without
dithiothreitol. The reaction concentrations of actin and pyrene maleimide
were initially 40 mM. The reaction solution was G buffer with 2 mMMgCl2
and 50 mM KCl added after the probe to promote actin polymerization at
room temperature for 30 min. Another equal aliquot of pyrene maleimide
was added for an additional 30 min. The labeled actin was then pelleted in a
Beckman TL-100 ultracentrifuge (Fullerton, CA). Actins were depolymer-
ized by dialysis against G buffer and stored in G buffer (pH 7.5) at 4C. The
labeling ratio was determined from the absorbance of bound pyrene
maleimide at 334 nm and was 1.6–1.9 mol of probe/mole of actin for S235C
and E224C actins, indicating labeling of both C374 and the cysteine
introduced by mutagenesis. For M305C actin, the labeling efﬁciency was
;1.4 mol of dye/mol of actin, suggesting that the sulfur at 305 was more
sequestered than the other residues.
Actin polymerization
Actin polymerization was carried out with 5 mM G-actin in G buffer in a
total volume of 120 ml in a thermostatted ﬂuorimeter cuvette. Polymeriza-
tion was initiated by addition of MgCl2 and KCl to ﬁnal concentrations of 2
and 50 mM, respectively, and formation of actin ﬁlaments was followed as
a function of time by monitoring the increase in light scattering with excita-
tion and emission wavelengths set at 360 nm. For these and all pyrene
ﬂuorescence measurements, we used a FluoroMax (Jobin Yvon, Edison, NJ)
ﬂuorescence spectrometer.
Fluorescence of pyrene maleimide-labeled actin
The ﬂuorescence of pyrene-labeled actins was monitored with an excitation
wavelength of 365 nm. Emission spectra were recorded between 370–550
nm, and the emission wavelength for single wavelength measurements was
385 nm.
To assess TM binding, varying amounts of TM in F-buffer were mixed
with 5 mM pyrene maleimide-labeled actin ﬁlaments. To correct for dilution
of the reaction solution by the addition of TM, an equal volume of the buffer
was mixed with the labeled actin ﬁlaments, and the change in the pyrene
ﬂuorescence was measured. Comparisons of the relative effects of cTM and
yeast TPM1 and TPM2 were performed using equal weights of the three
proteins to account for the differences in their molecular masses. This
approach normalized the data to the total number of quasirepeats present in a
TM sample.
To assess the effect of adding TN to the actin/TM complex, the pyrene
maleimide labeled actin/cTM complex was formed as described above. To
the solution was added 0.3 mM EGTA, pH 7.5, to chelate Ca21, and the
change in pyrene ﬂuorescence was measured. cTN, equimolar to the amount
of TM present, was then added, and the change in the ﬂuorescence was
measured.CaCl2, 0.3 mMwas then added, which saturated the TN, and the
change in the ﬂuorescence was measured again. Corrections for change in
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ﬂuorescence due to dilution from the added TN and Ca21 aliquots were
addressed as above.
Cosedimentation assay
Measurement of the binding of TM to F-actin using a centrifugation-based
assay was performed according to methods described previously (38) with
modiﬁcation as follows. G-actin, 10 mM, in the presence of various con-
centrations of TM was induced to polymerize by the addition of 2 mM
MgCl2 and 50 mM KCl. After incubation at room temperature for at least
30 min to ensure attainment of the steady state, the actin-TM solution was
centrifuged at 25C for 30 min in a Beckman TL-100 ultracentrifuge at
75,000 rpm. The pellet was dissolved in SDS sample buffer and was
subjected to 12.5% SDS-PAGE analysis. Gels were stained with Coomassie
blue, and the image of the gel was captured with an Epson Perfection 2450
photo scanner (Long Beach, CA). The intensities of the yeast actin and TM
bands were further quantiﬁed using UN-SCAN-IT (Silk Scientiﬁc, Orem,
UT) software. The ratio of the bound TPM1/pelleted actin band densities
were calculated at each point and normalized to the maximum ratio at
saturating TM concentrations. To check for extent of binding, at saturation,
the staining density of the individual bands were corrected for differences in
molecular weights. The TM band was further corrected to account for the
fact that the native protein is composed of two polypeptide chains. The ﬁnal
corrected ratio of the bands showed that at saturation the molar ratio of
bound TPM1/pelleted actin was ;1:5 as expected.
Calculation of the apparent binding afﬁnity
of actin to TM
The apparent binding constants (Kapp) and Hill coefﬁcents (aH) of cTM and
TPM1 binding to pyrene235 F-actin were determined by ﬁtting the data to
the Hill equation as described in Cho et al. (39) using Microsoft Excel
(Redmond, WA):
v ¼ n½TM
aH
K
aH
app
11 ½TMaHKaHapp
: (1)
The molar concentration of bound TM at each point was calculated as
follows. The total ﬂuorescence change at saturating TMwas set at 100% and
the fraction of this total change D was determined for each point assessed.
For cTM, at saturation, seven actins are covered by a single TM, so that for
5 mM actin, a 100% ﬂuorescence change would be caused by 0.71 mM TM.
Thus, the concentration of bound cTM at each point is 0.71D. Free TM is the
total TM – bound TM. For yeast TPM1, which only covers ﬁve actin
monomers, the calculation is made the same way except that 100% of the
ﬂuorescence change at saturating TM is caused by 1 mM TPM1.
Molecular distance calculations
Molecular distances in our modeling ﬁgures were determine using Swiss
PDB viewer, version 3.7 (http://www.expasy.ch/spdbv/mainpage.html)
applied to the atomic coordinates for a muscle F-actin trimer based on the
Holmes actin ﬁlament model (13).
RESULTS
To create a system to monitor TM binding from actin’s
perspective, we ﬁrst mutated yeast actin E224, S235, and M305
individually to C as potential ﬂuorescent probe attachment
sites (Fig. 1). We selected these residues because they were
on the surface of the protein, their side chains were facing
away from the body of the actin monomer, and an attached
pyrene should be located in a position that might be affected
by bound TM (13). The mutation at 224 was unique in that a
probe attached here would point away from, not toward, the
bound TM and would thus serve as a directional control. All
mutant actins were compatible with yeast viability and pro-
duced no observable defective phenotype, and the actins
behaved normally in our standard puriﬁcation protocol.
We reacted the mutant actins with at least a 2:1 molar ratio
of pyrene maleimide/actin, since the reactive C374 was also
present. The ﬂuorescence signal of C374 pyrene-labeled wild-
type (WT) actin does not change when it is mixed with TM
(37). To eliminate the potential for problems of interpretation
arising from the presence of multiple probes, we attempted to
replace the reactive C374 with an A. However, this change
caused puriﬁcation problems, even though we had success-
fully used the same approach with similar mutant actins (37).
Polymerization of mutant actins
By light scattering, all three unlabeled mutant actins
polymerized similarly to WT actin both in terms of rate
and extent (data not shown). The polymerization kinetics of
pyrene-labeled E224C and M305C actins were also similar to
the kinetics of pyrene-labeled WT actin (data not shown).
However, we observed increased light scattering with the
labeled S235C actin compared with WT actin. Examination
of polymerized pyrene-S235C actin by electron microscopy
showed that the light scattering increase was probably
caused by the formation of disordered ﬁlament bundles not
observed with the unlabeled mutant actin (Fig. 2 A).
Copolymerization of a 1:1 mixture of labeled and unlabeled
mutant actins caused the bundles to disappear (Fig. 2 B).
Addition of TM to pure labeled F-actin also caused the
disappearance of the bundles (Fig. 2 C).
Fig. 3 A shows that a polymerization-dependent increase
in ﬂuorescence for the pyrene-labeled S235C and pyrene WT
actins was roughly proportional to the extent of labeling of
the actin in comparison to that produced by WT actin labeled
at C374 alone. In the latter case, the labeling efﬁciency usu-
ally approaches 100%. Interestingly, the postpolymeriza-
tion ﬂuorescence spectrum of the C224-labeled actin (Fig.
3 B) showed the appearance of a new pyrene excimer band
(37,40), centered at ;490 nm, formed by the interaction of
the pyrene at C224 on one monomer with a pyrene at C374 of
another monomer on the opposing strand of the actin helix.
Effect of cTM on the ﬂuorescence of
pyrene-labeled E224C, S235C, and M305C actins
The addition of saturating amounts of cTM to pyrene-labeled
S235C F-actin produced a signiﬁcant increase in F-actin
ﬂuorescence (19%) at an emission wavelength of 385 nm
(Fig. 4 A). We next determined whether the bundling
described earlier affected the ﬂuorescence change of the
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labeled C235 F-actin when mixed with cTM. Using a
different preparation of labeled actin, we performed the
same experiment with 50% pyrene-labeled (no bundling)
and 100% pyrene-labeled (bundling) C235 F-actin. cTM
caused similar increases in the ﬂuorescence signals for 50%
(17% increase) and 100% (22% increase) labeled C235
F-actin, suggesting that the bundling does not signiﬁcantly
interfere with the ﬂuorescence change induced by cTM. We
therefore used completely labeled actin for the remainder of
our experiments. The different values for the 100% labeled
actin samples from different preparations can be explained
by slightly different degrees of attachment of pyrene to the
actin. Since only one of the two labeled sites is affected by
the TM, slight differences in the ratio of labeling of the two
sites can cause a difference in the percentage change in
ﬂuorescence values which are based on total ﬂuorescence.
Addition of cTM to either labeled M305C or E224C F-actin
resulted in no signiﬁcant increase in ﬂuorescence (data not
shown), in contrast to the case for labeled S235C F-actin. Also,
in agreement with previous results (37), addition of TM to
C374-labeled WT yeast F-actin produced no change in pyrene
ﬂuorescence. Cosedimentation experiments demonstrated that
FIGURE 2 Electron microscopic analysis of pyrene-labeled S235C actin
ﬁlaments. An aliquot of 5 mM actin, after inducement of polymerization by
addition of KCl and MgCl2, was examined by electron microscopy as
described in Materials and Methods. (A) pyrene-labeled S235C actin alone,
(B) a mixture of pyrene-labeled and unlabeled S235C actins at a 1:1 molar
ratio, or (C) pyrene-labeled S235C actin with cTM at 2:1 molar ratio. Bar ¼
10 mm.
FIGURE 3 The ﬂuorescence emission spectrum of pyrene-labeled WT,
S235C, and E224C F-actin. Each pyrene-labeled actin was triggered to
polymerize until the steady state was reached, and the emission spectrum of
each sample from 370 to 550 nm was recorded as described in Materials and
Methods. Excitation wavelength was 365 nm. (A) 5 mM pyrene WT (line 1)
and pyrene-S235C (line 2). (B) 2.5 mM pyrene-E224C before (line 1) and after
(line 2) polymerization. The inset is the difference spectrum for these plots.
The excimer peak at 490 nm is denoted by an arrow.
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binding of the TM to the labeled actins was normal (data not
shown). Thus, the TM-dependent change in ﬂuorescence of
the probe at C235 is extremely position speciﬁc.
Comparison of the effect of cTM, skTM, and yeast
TPM1 and TPM2 on the ﬂuorescence of
pyrene-labeled S235C actin
Lehman et al. (18) previously showed that rabbit skTM, a
mixture of the a- and b-isoforms, bound in the C-state to
skeletal muscle actin and cTM (85% a) bound in the B-state.
The skTM mixture is ;60% a,a dimer and 40% a,b dimer;
the a and b polypeptides differ from one another at 39
positions, only two of which involve charged residues (41).
However, the same skTM mixture bound to yeast F-actin in
the B-state, far away from the probes we engineered into the
actin. Fig. 4 B shows that the addition of saturating amounts
of the same skTM mixture to C235-pyrene actin caused a
6–7% increase in F-actin ﬂuorescence in comparison with
the 20% observed with cTM (Fig. 4 A). This result suggested
that cTM and skTM might bind to different parts of the yeast
actin ﬁlament but in the opposite order compared with that
observed with muscle actin.
We next compared the abilities of yeast TPM1, TPM2,
and cTM to alter the ﬂuorescence of the pyrene-labeled
S235C actin. Overall, yeast TPM1 and TPM2 are 64.5%
identical (1); however, removal of a large insert present in
TPM1 but not TPM2 raises the identity to 85%. For yeast
TPM1 and TPM2, the molar ratios of TM/actin used were
greater than that used for the binding of cTM to account for
the fact the TPM1 is roughly 5/7 and TPM2 is 4/7 the length
of cTM. The percentage increase caused by the yeast TPM1
at saturating concentrations was slightly but reproducibly
less than that caused by cTM, whereas that caused by TPM2
was larger than that of cTM (Table 1). This result suggests
that the two yeast TPM isoforms do not bind to the same sites
on F-actin.
Relationship of the extent of increased
ﬂuorescence to the extent of TM binding
We wished to know whether there was a stoichiometric
relationship between TM binding and increased actin
ﬂuorescence or whether substoichiometric amounts of TM
caused long-range changes in actin conformation. We thus
assessed the increase in C235 probe ﬂuorescence resulting
from the addition of increasing amounts of cTM or yeast
TPM1 to a constant amount of labeled F-actin. In both cases,
a 1:4 mixture of TM/yeast actin produced saturable binding
as previously reported (8).
Fig. 5 A shows that the ﬂuorescence change with yeast
TPM1 resembles a typical saturable cooperative TM binding
curve. A centrifugation assay conﬁrmed that the increase in
ﬂuorescence reﬂected an increase in TM binding. We further
ﬁtted the ﬂuorescence data to the Hill equation (39). The
results yielded a Kapp of 2.34 6 0.70 310
6 M1 (average of
three individual experiments), similar to the result obtained by
Strand et al. (42) ofKapp¼ 1.423 106M1 usingmuscle actin
and recombinant TPM1. Fig. 5 B shows that the ﬂuorescence
change caused by the binding of cTM is also cooperative with
a Kapp of 2.79 3 10
6 M1 (averaging from two individual
experiments), again, similar to the Kapp ¼ 2.3 6 0.6 3 106
M1 from Korman and Tobacman (38) using yeast actin and
cTM, demonstrating the validity of our approach.
Effect of TN 6 Ca21 on TM-dependent increase
in ﬂuorescence of pyrene-labeled S235C F-actin
Previous models of the calcium-dependent regulation of
muscle contraction predict a Ca21-TN-dependent modula-
tion of TM binding to the actin ﬁlament surface. We deter-
mined whether the ﬂuorescence of labeled F-actin was
sensitive to such modulation. Saturating cTM was added to
F-actin followed by enough EGTA to complex the calcium.
The resulting emission spectrum of the TM-actin complex
showed no EGTA-dependent change. A molar amount of
cTN, equal to the amount of cTM, was introduced, and the
emission spectrum was again recorded. Finally, enough
FIGURE 4 Change in ﬂuorescence of pyrene-labeled S235C actin after
addition of saturating amounts of cTM (A) or skTM (B). The experiment was
performed as described in Materials and Methods. (Solid lines) F-actin only;
(dashed lines) F-actin 1 TM.
TABLE 1 Summary of the effects of saturating amounts
of different TMs on the ﬂuorescence of pyrene-labeled
S235C F-actin
CTM skTM TPM1 TPM2
F-actin 21.5% 7.25% 15.5% 24%
61.7% 62.6% 1/1% 1/2%
(n ¼ 4) (n ¼ 4) (n ¼ 2) (n ¼ 2)
For these determinations, 6 represents SD, whereas 1/ represents the
range after the averaging of two values.
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calcium was added to achieve a ﬁnal concentration of 0.3
mM, and the emission spectrum was recorded again.
The results of this experiment are shown in Fig. 6 A. The
addition of TN caused a decrease in the ﬂuorescence of the
TM-actin solution to near that obtained with actin alone. As a
control, TN in the absence of TM had no effect on probe
ﬂuorescence (data not shown). Addition of calcium to the
actin-TM-TN complex caused a subsequent increase in
ﬂuorescence but not back to the level caused by the presence
of TM alone. If the difference in ﬂuorescence between
F-actin and actin 1 TM represents 100%, addition of Ca21
caused a ﬂuorescence gain of 22.2 6 6.6% (n ¼ 5) of this
difference or 4.2% of the initial F-actin ﬂuorescence. In each
experiment, the ﬂuorescence observed after addition of Ca21
exceeded the ﬂuorescence in the presence of TM and TN
alone. The size of the standard deviation probably reﬂects the
ratio of labeling of the 235–374 residues in different actin
preparations as discussed above. We did not repeat this
experiment with yeast TMs since they do not bind to TN.
Next, we determined if saturation of the TN-dependent
ﬂuorescence might occur at subsaturating TN concentrations.
In other words, with our system, could we demonstrate co-
operative effects of TN on the TM conformation reported
by the pyrene at residue 235? We repeated the experiment
shown in Fig. 6 Awith different amounts of TN in the absence
of calcium. As shown in Fig. 7, the effect of TN addition
follows a linear relationship until a plateau is reached at a 1:7
ratio of TN/actin complex. This linear relationship between
the effect of TN and the ratio of TN/actin/TM complex
suggests that the binding of TN to one molecule of TM does
not affect neighboring TMs in a cooperative fashion. This
experiment was performed twice with the same result. This
result agrees with a previous study by Hill et al. (43), who
carried out an analysis of the effect of TN on TMbinding via a
cosedimentation assay and concluded the effect of TN on a
particular TM did not extend to neighboring TMs.
Effect of an A230Y mutation on behavior
of pyrene at residue 235
Saeki and Wakabayashi (44) previously showed that alter-
ation of A230 to tyrosine (A230Y) did not affect the binding
of TM to actin but resulted in a hyperresponsive Ca21-
dependent stimulation of actomyosin ATPase activity in the
presence of TM and TN. This result suggested that the
mutation in subdomain 4 caused a conformational change in
the actin-myosin binding site involving subdomains 1 and 2
that led to this hyperactivation. This mutation might also
affect the TM-dependent behavior of the pyrene at residue
235 if similar conformation changes were involved in the
ﬂuorescence enhancement.
We thus examined the ﬂuorescence behavior of labeled
A230Y/actin in the presence of cardiac-TM/TN1 Ca21. The
A230Ymutation does not affect the starting actin ﬂuorescence
(compare Fig. 6, A and B), the TM-induced ﬂuorescence
increase, or the ﬂuorescence decrease after addition of the TN.
However, using the same analysis employed in Fig. 6 A, the
A230Y/actin recovers about twice the ﬂuorescence difference
as does the S235C actin at this position, 52% with a range of
;12% based on two determinations. This result indicates
communication between the 230 helix on one hand and TM
bound in theC-state on the other, probably via conformational
changes involving these two separate areas of the actin.
DISCUSSION
We show that a pyrene at residue 235 of yeast actin provides
a novel and sensitive ﬂuorescence-based assay for assessing,
FIGURE 5 Comparison of the titration curves for the binding of yeast
TPM1 and cTM to pyrene-labeled S235C F-actin using ﬂuorescence and
cosedimentation assays. (A) The pyrene ﬂuorescence of 5 mM F-actin at 385
nm was recorded before and after the addition of increasing concentration of
TPM1. The excitation wavelength was 365 nm. The maximum difference in
ﬂuorescence, shown on the left vertical axis, was set at 100%. Other values
were normalized to this number and plotted against the concentration of
TPM1 added to the sample. Two separate experiments (d, ¤) are shown. A
cosedimentation analysis of the reaction, using SDS-PAGE analysis of the
proteins in the pelleted fraction, was performed as described in Materials and
Methods. The ratios of the intensity of the pelleted TPM1 bands versus the
pelleted actin bands at each point were calculated, normalized to the
maximum ratio at saturation, and plotted as % maximum TPM1 bound on
the right vertical axis (:). (B) Titration curve for the binding of cTM to
pyrene-labeled mutant S235C F-actin. The experiment was performed as in
panel A. The results of two separate experiments (n, d) are shown.
Cosedimentation analysis was not performed with this TM.
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in solution, the binding of TM to F-actin. This assay can
detect differences in the interactions of speciﬁc TM isoforms
with actin, and it can detect changes in TM positioning
brought about by factors that promote TM movement.
The increase in actin ﬂuorescence caused by TM binding
could be theoretically due to either an interaction of the
TM with the probe, per se, or a TM-induced change in
conformation of the actin in the vicinity of the probe leading
to an altered probe environment. The distance between the
sulfur on C235 to the tip of the attached pyrene is ;9 A˚. The
distance from the –SH (sulfhydryl group) to the edge of the
TM envelope for a C-state bound molecule is;20 A˚. The 11
A˚ gap between these measurements, together with the
speciﬁcity of the probe response, suggests that the TM-
dependent enhancement of pyrene235 ﬂuorescence is due to a
TM-induced conformational change in the actin and not a
direct TM-probe interaction. If true, the ﬂuorescence change
would be brought about by allosteric interactions between
the small outer domain of actin (subdomains 1 and 2) and the
larger inner domain (subdomains 3 and 4) in which residue
235 resides. The effect of the subdomain 4 A230Y mutation
on the interaction of actin with TM/TN and with myosin on
the outside of the actin ﬁlament on subdomains 1 and 2 is
consistent with such interactions.
Our work suggests that the differential enhancement in
pyrene ﬂuorescence caused by cTM versus skTM results
from the binding of the two TMs to different sites on the
yeast actin surface. A possible alternative explanation is that
both TMs bind to the same site, but the differences in amino
acid sequences of the two TMs result in different conforma-
tional changes in the area of the probe. However, this latter
possibility seems less likely. EM (17,18) shows that these
two TMs bind to different places on the surface of muscle
actin. Second, skTM, which binds near the interdomain cleft
of actin in muscle actin, binds near the outside of the ﬁlament
on yeast actin. One might thus infer that with yeast actin, the
relative binding positions of these two TMs have been
reversed: cTM is away from the outer edge in the C-position.
The TN-induced decrease in the ﬂuorescence of the actin-
cTM complex to that of actin alone supports our hypothesis
since TN clamps TM on the ﬁlament at or near where skTM
resides. Although the ﬂuorescence changes for the mamma-
lian TMs seem consistent with the structural work, we cannot
exclude the possibility of sequence-speciﬁc effects at this
time.
The small increase in pyrene ﬂuorescence caused by
skTM might reﬂect a minor portion of the protein binding in
the C-position. Such binding would agree with Lorenz’s
proposal (13) that the actin-TM interaction can be approx-
imated by a broad energy well, controlled by ionic interac-
tions between the two proteins, in which substantial
movement of the TM occurs. Helical averaging over long
stretches of ﬁlament used originally for the EM reconstruc-
tions might have caused a smaller second TM population to
FIGURE 6 Effect of cTM, cTN, and Ca21 on the
ﬂuorescence of pyrene-labeled A230Y/S235C actin. TM,
1.2 m M, was added to 5 mM pyrene-labeled F-actin
polymerized by the addition of 2 mM MgCl2 and 50 mM
KCl. EGTA was added to remove calcium from the
solution. cTN, 1.2 mM, was then added followed by the
addition of enough calcium to produce a ﬁnal concentra-
tion of 0.3 mM. Beginning with F-actin, the ﬂuorescence
spectrum was recorded after each addition using an
excitation wavelength of 365 nm. Addition of EGTA
caused no change in the ﬂuorescence spectrum (data not
shown). F-actin (solid line); after TM addition (solid line
with h); after TN addition (dashed line with )); after
calcium addition (solid line with 3). (A) S235C actin; (B)
A230Y/S235C actin.
FIGURE 7 Effect of increasing TN concentration on the ﬂuorescence of
the complex of labeled S235C actin with cTM. TM, 1.2 mM, and 5 mM
pyrene-labeled F-actin were combined, and the ﬂuorescence at 385 nm
recorded. EGTA was added to remove calcium, and increasing amounts of
cTN were added as indicated. The magnitude of the ﬂuorescence decrease
caused by each addition was plotted against the ratio of [TN]/[actin]. The
excitation wavelength was 365 nm. Shown is a representative sample of two
different experiments.
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be missed. Recent work from the same laboratory using
single particle analysis comparing regulated muscle thin
ﬁlaments in the presence and absence of Ca12 shows two
distinct populations of TM on the actin surface (45).
The effects of addition of Ca12 on the ﬂuorescence of
the TN/TM-actin complex correlate with the predictions of
the three-state model of Geeves and co-workers (16). The
calcium-dependent increase in ﬂuorescence of the cTM/TN/
actin complex would be caused by the movement of the
TM back toward the C-position. The failure to return to the
original cTM/actin ﬂuorescence level suggests that the
movement of the TM in the presence of TN does not reach
the same position the TM occupied in the absence of TN.
This decreased ﬂuorescence gain might involve an effect
caused by the TN as part of a TN/TM complex, but it is likely
not caused by the interaction of TN with the actin per se since
TN had no effect on the probe 235 ﬂuorescence in the
absence of TM as described in Results.
An enhanced ﬂuorescence recovery associated with the
A230Y mutation when calcium is added to the TN/TM/actin
complex was observed. This result suggests that this
mutation causes an allosteric change that makes the C-state
more accessible. It cannot be caused by the effect of the
A230Y mutation on the probe per se, since cTM causes
the same ﬂuorescence change in the presence or absence of
the A230Y mutation. An increased C-state accessibility
would be consistent with the hypercontractility seen with
this mutant actin in the presence of calcium, TM, and TN,
since it would result in greater access of the myosin head to
its binding site on the actin surface.
There is precedence for such a proposal since a mutation
in the inner domain of actin has been shown to affect TM
binding to the outer domain. Korman and Tobacman (38)
demonstrated that mutations at residues 315/316 of actin
resulted in decreased binding of TM to the actin ﬁlament.
The actin structure provides a clue as to how such an
allosteric change might occur. A potentially close contact
exists between the two major actin domains at the top of the
interdomain cleft around the positions of Arg62 and Thr203.
Furthermore, Thr203 on the edge of the cleft is on a strand
that runs directly to the 223–231 helix (27). Interestingly, the
TM envelope in the C-state contacts these apposing residues,
potentially forming a bridge between the secondary struc-
tural elements in which they reside (18).
Possible different modes of binding of related TMs to
actin is not conﬁned to mammalian TMs. Yeast TPM1 and
TPM2 appear to exhibit an analogous difference (1). The
smaller ﬂuorescence difference observed with the yeast TMs
suggests that they may be binding much closer to one
another on the actin surface than do the two muscle TMs.
Again, the structural work has not been performed that
would allow conﬁrmation of this postulate. Earlier experi-
ments with these two proteins suggested they had over-
lapping but partially different functions in the yeast cell, and
our results here provide physical evidence for differential
binding that could lead to differential function (1,11,42).
Nonmuscle TMs from higher cells also fall into two different
molecular size classes (46). The larger ones, with seven
pseudorepeats, are predominant innonmalignant cells,whereas
the smaller ones predominate in malignant cells (46). Up-
regulation of the larger TMs can cause reversal of the
malignant phenotype, but nothing is known about the un-
derlying biochemicalmechanisms bywhich these changes are
regulated (47). The system we have developed here may
provide an avenue for increasing our understanding of the
roles of the two TMs in yeast at the molecular level. Ulti-
mately, it may also be useful in ascertaining the differences in
the two classes of nonmuscle TMs from higher cells as well.
Finally, the observance of an excimer peak after poly-
merization of actin labeled at positions 374 and 224 with
pyrene provides important insight into the structure of the
actin ﬁlament. Excimer formation by pyrene maleimides
attached to Cys spacially separated Cys residues requires a
distance of ;15–8 A˚ between the two sulfurs (40). This
distance ﬁts well with the structural constraints of the
Holmes actin ﬁlament model, which predicts an intersulfur
distance of ;21 A˚ (Fig. 1 B). Considering the dynamic
ﬂexibility of the C-terminal actin peptide (48), this additional
6 A˚ space could easily be traversed. Within F-actin, the
224–224 and 374–374 distances are each .50 A˚. This fact,
combined with the presence of large amounts of protein mass
directly between cysteines in each of these two pairs, would
exclude these last two alternatives as explanations for the
excimer. The structural constraint arising from our experi-
ment can be added to those imposed from previous studies
using either intermonomer cross-linking (49,50) or excimer
ﬂuorescence studies in deﬁning a ﬁnal model of the actin
ﬁlament (37,51).
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